Accounting assumption that the impact of COVID-19 would continue into the fiscal year ending March 2022
First written in FY2021-Q3. 8 of 12 entries say "Restated". Latest entry: FY2025.
- FY2025DroppedAnnual report
「These estimates may be affected by changes in future uncertain economic conditions and other factors. If the timing and amount of actual taxable income differ from the estimates, this may have a material impact on the amount of deferred tax assets in the consolidated financial statements for the following consolidated fiscal year.」
The accounting assumption that the impact of COVID-19 would continue is not described in this year's annual filing, and significant accounting estimates are addressed in terms of the recoverability of deferred tax assets. - FY2024-Q3RestatedAnnual report
「There have been no material changes to the assumptions, including the timing of the end of the COVID-19 pandemic, described under “Significant Accounting Estimates” in the annual securities report for the previous consolidated fiscal year.」
The company states that there have been no material changes to its accounting assumptions concerning the timing of the resolution of COVID-19 and related matters. - FY2024-Q2RestatedAnnual report
「There have been no material changes to the assumptions, including the timing of the end of the COVID-19 pandemic, described under “Significant Accounting Estimates” in the annual securities report for the previous consolidated fiscal year.」
The filing states that there were no material changes from the previous consolidated fiscal year in the accounting assumptions concerning when COVID-19 and related effects would subside. - FY2024-Q1RestatedAnnual report
「There have been no material changes to the assumptions, including the timing of the end of the COVID-19 pandemic, described under “Significant Accounting Estimates” in the annual securities report for the previous consolidated fiscal year.」
The filing states that there were no material changes from the previous consolidated fiscal year in the accounting assumptions concerning when COVID-19 and related effects would subside. - FY2023MitigatedAnnual report
「Regarding the impact of COVID-19 on sales forecasts and other matters, it remains difficult to predict when the impact will subside. However, the Group assumes that the impact will be limited as economic activity normalizes due to the easing of measures to control the infection and other factors.」
Although the qualification that it is difficult to predict when the impact of the pandemic will subside remains, the accounting assumptions treat the impact as limited in light of the normalization of economic activity. - FY2023-Q3RestatedAnnual report
「There have been no material changes to the assumptions, including the timing of the end of the COVID-19 pandemic, described under “Significant Accounting Estimates” in the annual securities report for the previous consolidated fiscal year.」
The filing states that there were no material changes from the previous consolidated fiscal year in the accounting assumptions concerning when COVID-19 and related effects would subside. - FY2023-Q2RestatedAnnual report
「There have been no material changes to the assumptions, including the timing of the end of the COVID-19 pandemic, described under “Significant Accounting Estimates” in the annual securities report for the previous consolidated fiscal year.」
The filing states that there were no material changes from the previous consolidated fiscal year in the accounting assumptions concerning when COVID-19 and related effects would subside. - FY2022SoftenedAnnual report
「Regarding the impact of COVID-19 on sales forecasts and other matters, it remains difficult to accurately predict when the impact will subside. However, the Group assumes that the impact will continue during fiscal 2022 but trend downward as economic activity and measures to control the infection increasingly coexist.」
The accounting assumption has changed to reflect that, although the impact of the pandemic will continue through fiscal 2022, it will trend downward as economic activity and infection control measures are balanced. - FY2022-Q3RestatedAnnual report
「There have been no material changes to the assumptions, including the timing of the end of the COVID-19 pandemic, described under “Significant Accounting Estimates” in the annual securities report for the previous consolidated fiscal year.」
The filing states that there were no material changes from the previous consolidated fiscal year in the accounting assumptions concerning when COVID-19 and related effects would subside. - FY2022-Q1RestatedAnnual report
「There have been no material changes to the assumptions, including the timing of the end of the COVID-19 pandemic, described under “Significant Accounting Estimates” in the annual securities report for the previous consolidated fiscal year.」
The filing states that there were no material changes from the previous consolidated fiscal year in the accounting assumptions concerning when COVID-19 and related effects would subside. - FY2021RestatedAnnual report
「Although infections are expected to subside as vaccinations progress, we assume that the impact will continue through fiscal 2021.」
The Group continues to assume for accounting purposes that the impact of COVID-19 will continue through fiscal 2021. The filing states that it is difficult to accurately predict when the pandemic will subside. - FY2021-Q3WorsenedAnnual report
「The Group had assumed that the impact of COVID-19 would subside during the fiscal year ending March 2021 and that economic activity would recover, as described in the assumptions, including the timing of the end of COVID-19, in the "Additional Information" section of the annual securities report for the previous consolidated fiscal year under "Assumptions concerning the impact of COVID-19 in making accounting estimates." However, because it remains difficult to accurately predict when the impact will subside, the assumption has been changed to assume that the impact will continue into the fiscal year ending March 2022.」
The Group changed its previous assumption that the impact of COVID-19 would subside during the fiscal year ending March 2021 to an assumption that the impact would continue into the fiscal year ending March 2022. Although the assumed period of the pandemic's impact was extended, the filing states that the change had no material impact on the quarterly consolidated financial statements.